跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EFEDRINA FRESENIUS KABI 30 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EFEDRINA FRESENIUS KABI 30 MG/ML SOLUCION INYECTABLE
Approved
STANDARD
EFEDRINA FRESENIUS KABI 30 MG/ML SOLUCION INYECTABLE
Fresenius Kabi España, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 17, 2024
Approval ID
d3fed15037e66c9b
Company
Fresenius Kabi España, S.A.U.
Type
Standard
Approval Details
Approval Id
d3fed15037e66c9b
Drug Cima Aemps Name
EFEDRINA FRESENIUS KABI 30 MG/ML SOLUCION INYECTABLE
Register Number
89573
Holder Company Name
Fresenius Kabi España, S.A.U.
Marketing Company Name
Fresenius Kabi España, S.A.U.
Authorization Date
2024-05-17
Dosage Form
SOLUCIÓN INYECTABLE
Dose
30 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Fresenius Kabi España, S.A.U.
Active Ingredients
EFEDRINA HIDROCLORURO
30 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 17, 2024
Approval ID
d3fed15037e66c9b
Type
Standard
Back to CIMA-AEMPS Approvals
